BACKGROUND: Total body photography (TBP) and dermatoscopy are imaging techniques used to treat patients with pigmented lesions. OBJECTIVE: We sought to describe use, training, logistics, and beliefs about these tools among residency programs and to assess changes during a 10-year period. METHODS: Surveys were sent to all directors (n = 111) and chief residents (n = 109) of US dermatology training programs. RESULTS: A total of 83 (74.8%) attendings answered the questionnaire. In all, 59 (71.1%) reported using TBP, an 11.9% increase (P = .2484) over the past decade. Reasons for using TBP included: reduces patient anxiety (81.4%), helps detect early melanoma (78.0%), and leads to fewer biopsies (66.1%). Logistical (79.2%) and financial (45.8%) constraints were reasons for not using TBP. Seventy respondents (84.3%) reported using dermatoscopy, a 40.0% increase (P = .0001) over the 10-year period. Reasons for dermatoscopy use were consistent over time: helps find melanoma in curable stage (75.7%), reduces patient anxiety (61.4%), and leads to fewer biopsies (57.1%). The most common reason for not using dermatoscopy remained lack of training (38.5%). A total of 92 (84.4%) residents completed their survey, of which 41 (44.6%) and 81 (88.0%) reported using TBP and dermatoscopy, respectively. In all, 62 (67.4%) and 79 (85.9%) respondents would prefer additional training in TBP and dermatoscopy, respectively. LIMITATIONS: Results may not be applicable to the general dermatology community. CONCLUSIONS: Use of dermatoscopy among residency programs has increased significantly during the last decade. A more modest increase in the use of TBP was observed. Barriers to diffusion of these technologies into practice persist, including insufficient logistics and training. Copyright 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
BACKGROUND: Total body photography (TBP) and dermatoscopy are imaging techniques used to treat patients with pigmented lesions. OBJECTIVE: We sought to describe use, training, logistics, and beliefs about these tools among residency programs and to assess changes during a 10-year period. METHODS: Surveys were sent to all directors (n = 111) and chief residents (n = 109) of US dermatology training programs. RESULTS: A total of 83 (74.8%) attendings answered the questionnaire. In all, 59 (71.1%) reported using TBP, an 11.9% increase (P = .2484) over the past decade. Reasons for using TBP included: reduces patientanxiety (81.4%), helps detect early melanoma (78.0%), and leads to fewer biopsies (66.1%). Logistical (79.2%) and financial (45.8%) constraints were reasons for not using TBP. Seventy respondents (84.3%) reported using dermatoscopy, a 40.0% increase (P = .0001) over the 10-year period. Reasons for dermatoscopy use were consistent over time: helps find melanoma in curable stage (75.7%), reduces patientanxiety (61.4%), and leads to fewer biopsies (57.1%). The most common reason for not using dermatoscopy remained lack of training (38.5%). A total of 92 (84.4%) residents completed their survey, of which 41 (44.6%) and 81 (88.0%) reported using TBP and dermatoscopy, respectively. In all, 62 (67.4%) and 79 (85.9%) respondents would prefer additional training in TBP and dermatoscopy, respectively. LIMITATIONS: Results may not be applicable to the general dermatology community. CONCLUSIONS: Use of dermatoscopy among residency programs has increased significantly during the last decade. A more modest increase in the use of TBP was observed. Barriers to diffusion of these technologies into practice persist, including insufficient logistics and training. Copyright 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
Authors: Niels Kvorning Ternov; T Vestergaard; L Rosenkrantz Hölmich; K Karmisholt; A L Wagenblast; H Klyver; M Hald; L Schøllhammer; L Konge; A H Chakera Journal: Arch Dermatol Res Date: 2020-06-28 Impact factor: 3.017
Authors: Hyuk C Cha; Mandy Harting; Kelly B Cha; Mathew W Ludgate; Stephen H Olsen; Lili Zhao; Christopher D Lao Journal: J Am Acad Dermatol Date: 2012-05 Impact factor: 11.527
Authors: Lynn T Dengel; Gina R Petroni; Joshua Judge; David Chen; Scott T Acton; Anneke T Schroen; Craig L Slingluff Journal: Int J Dermatol Date: 2014-12-16 Impact factor: 2.736
Authors: J Malvehy; A Hauschild; C Curiel-Lewandrowski; P Mohr; R Hofmann-Wellenhof; R Motley; C Berking; D Grossman; J Paoli; C Loquai; J Olah; U Reinhold; H Wenger; T Dirschka; S Davis; C Henderson; H Rabinovitz; J Welzel; D Schadendorf; U Birgersson Journal: Br J Dermatol Date: 2014-10-19 Impact factor: 9.302